Parvovirus B19 infection during pregnancy
Parvovirus B19 (B19V) is a widespread pathogen causing infection that occurs mostly in children. Even though infection of B19V is mainly asymptomatic, it can bring about a few conditions that may require medical intervention, including erythema infectiosum (fifth disease), slapped cheek syndrome, pa...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2022-07-01
|
| Series: | Current Issues in Pharmacy and Medical Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/cipms-2022-0008 |
| _version_ | 1818502786589917184 |
|---|---|
| author | Pietruszka Katarzyna Sliwinska Magdalena Sikora Agnieszka |
| author_facet | Pietruszka Katarzyna Sliwinska Magdalena Sikora Agnieszka |
| author_sort | Pietruszka Katarzyna |
| collection | DOAJ |
| description | Parvovirus B19 (B19V) is a widespread pathogen causing infection that occurs mostly in children. Even though infection of B19V is mainly asymptomatic, it can bring about a few conditions that may require medical intervention, including erythema infectiosum (fifth disease), slapped cheek syndrome, papular-purpuric gloves and socks syndrome (PPGSS), as well as other disorders related to the hematological system. Despite the fact that the most common route of transmission is through the respiratory system, B19V can be also transmitted transplacentally from mother to foetus. Vertical transmission may lead to myocarditis, thrombocytopenia, neural manifestations, and foetal hydrops, which may be life-threatening conditions to both mother and foetus. Detection of B19V infection is based mostly on molecular and serological screening and it is performed after suspected exposure to pathogen or exhibition of symptoms. Currently, there is no specific medication against B19V infection, therefore, treatment is based on the elimination of symptoms. New therapies are, however, under development. |
| first_indexed | 2024-12-10T21:15:05Z |
| format | Article |
| id | doaj.art-8ec0db24cc4c4169bbb92c80829b7983 |
| institution | Directory Open Access Journal |
| issn | 2300-6676 |
| language | English |
| last_indexed | 2024-12-10T21:15:05Z |
| publishDate | 2022-07-01 |
| publisher | Sciendo |
| record_format | Article |
| series | Current Issues in Pharmacy and Medical Sciences |
| spelling | doaj.art-8ec0db24cc4c4169bbb92c80829b79832022-12-22T01:33:20ZengSciendoCurrent Issues in Pharmacy and Medical Sciences2300-66762022-07-01351414610.2478/cipms-2022-0008Parvovirus B19 infection during pregnancyPietruszka Katarzyna0Sliwinska Magdalena1Sikora Agnieszka2Student Scientific Club, Department of Medical Microbiology, Medical University of Lublin, PolandIntercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, PolandDepartment of Medical Microbiology, Medical University of Lublin, PolandParvovirus B19 (B19V) is a widespread pathogen causing infection that occurs mostly in children. Even though infection of B19V is mainly asymptomatic, it can bring about a few conditions that may require medical intervention, including erythema infectiosum (fifth disease), slapped cheek syndrome, papular-purpuric gloves and socks syndrome (PPGSS), as well as other disorders related to the hematological system. Despite the fact that the most common route of transmission is through the respiratory system, B19V can be also transmitted transplacentally from mother to foetus. Vertical transmission may lead to myocarditis, thrombocytopenia, neural manifestations, and foetal hydrops, which may be life-threatening conditions to both mother and foetus. Detection of B19V infection is based mostly on molecular and serological screening and it is performed after suspected exposure to pathogen or exhibition of symptoms. Currently, there is no specific medication against B19V infection, therefore, treatment is based on the elimination of symptoms. New therapies are, however, under development.https://doi.org/10.2478/cipms-2022-0008parvovirus b19pregnancyfoetuscongenital infectionsnonimmune hydrops fetalisdiagnosis |
| spellingShingle | Pietruszka Katarzyna Sliwinska Magdalena Sikora Agnieszka Parvovirus B19 infection during pregnancy Current Issues in Pharmacy and Medical Sciences parvovirus b19 pregnancy foetus congenital infections nonimmune hydrops fetalis diagnosis |
| title | Parvovirus B19 infection during pregnancy |
| title_full | Parvovirus B19 infection during pregnancy |
| title_fullStr | Parvovirus B19 infection during pregnancy |
| title_full_unstemmed | Parvovirus B19 infection during pregnancy |
| title_short | Parvovirus B19 infection during pregnancy |
| title_sort | parvovirus b19 infection during pregnancy |
| topic | parvovirus b19 pregnancy foetus congenital infections nonimmune hydrops fetalis diagnosis |
| url | https://doi.org/10.2478/cipms-2022-0008 |
| work_keys_str_mv | AT pietruszkakatarzyna parvovirusb19infectionduringpregnancy AT sliwinskamagdalena parvovirusb19infectionduringpregnancy AT sikoraagnieszka parvovirusb19infectionduringpregnancy |